Lataa...
Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
Nitroglycerin (NTG), a drug that has been in clinical use for more than a century, has a range of actions which make it of particular interest in an oncological setting. It is generally accepted that the main mechanism of action of NTG is via the production of nitric oxide (NO), which improves cardi...
Tallennettuna:
| Julkaisussa: | Ecancermedicalscience |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cancer Intelligence
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4583240/ https://ncbi.nlm.nih.gov/pubmed/26435741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.568 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|